In conclusion, our data describe a YAP-HMGB1 signaling axis that mediates YAP promoting autophagic activity and tumorigenicity in GBM, and provide a basis for the development of alternative strategies, such as combination therapy with autophagy inhibitors for YAP high GBM patients. The gene discussed is HMGB1; the disease is glioblastoma.